wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38797428-35BA7A52-45B6-4808-812A-2AB3E2F52275
Q38797428-35BA7A52-45B6-4808-812A-2AB3E2F52275
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38797428-35BA7A52-45B6-4808-812A-2AB3E2F52275
Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease.
P2860
Q38797428-35BA7A52-45B6-4808-812A-2AB3E2F52275
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38797428-35BA7A52-45B6-4808-812A-2AB3E2F52275
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3e094c9e6e270c2cea7b6c744549bf1d4b8ebb29
P2860
A double-blind, placebo-controlled, ascending-dose, randomized study to evaluate the safety, tolerability and effects on cognition of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment.